To support the pre-clinical development of new cardiovascular medicines and technologies so that they are attractive for follow-on funding.
The award will help to bridge the funding gap between promising innovations and the clinic with the aim of accelerating advances in cardiovascular science for patient benefit.
- The BHF will be moving to a new research Grants Management System.
- We are not currently accepting applications for Translational Awards.
- Applications will re-open on our new Flexi-Grant® GMS in January 2020.
Please note: We have made changes to the Translational Award. The maximum allowable budget for the overall project has increased to £750,000.
Who can apply
- The principal investigator will be a researcher working in an established research institution in the UK.